Life Science Washington submitted the letter below to theWashington Department of Health requesting that two groups of high-risk essential life science employees be prioritized for early access to COVID-19 vaccines. Our letter is consistent with BIO and AdvaMed requests for prioritization in the CDC’s Advisory Council on Immunization Practices (ACIP) framework.